CBR00727
N-Methyl-1-(3-pyridin-2-yl-1,2,4-oxadiazol-5-yl)methanamine trifluoroacetate
AldrichCPR
Manufacturer: Sigma Aldrich
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | CBR00727-1-G | In Stock | ₹ 7,361.00 |
CBR00727 - 1 G
In Stock
Quantity
1
Base Price: ₹ 7,361.00
GST (18%): ₹ 1,324.98
Total Price: ₹ 8,685.98
form
solid
SMILES string
CNCC1=NC(C2=CC=CC=N2)=NO1.O=C(C(F)(F)F)O
InChI
1S/C9H10N4O.C2HF3O2/c1-10-6-8-12-9(13-14-8)7-4-2-3-5-11-7;3-2(4,5)1(6)7/h2-5,10H,6H2,1H3;(H,6,7)
InChI key
OUFCGDLCPNGVPI-UHFFFAOYSA-N
Related Products
Description
- Other Notes: Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
- Legal Information: Product of ChemBridge Corp.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
form: solid
SMILES string: CNCC1=NC(C2=CC=CC=N2)=NO1.O=C(C(F)(F)F)O
InChI: 1S/C9H10N4O.C2HF3O2/c1-10-6-8-12-9(13-14-8)7-4-2-3-5-11-7;3-2(4,5)1(6)7/h2-5,10H,6H2,1H3;(H,6,7)
InChI key: OUFCGDLCPNGVPI-UHFFFAOYSA-N
form:
solid
SMILES string:
CNCC1=NC(C2=CC=CC=N2)=NO1.O=C(C(F)(F)F)O
InChI:
1S/C9H10N4O.C2HF3O2/c1-10-6-8-12-9(13-14-8)7-4-2-3-5-11-7;3-2(4,5)1(6)7/h2-5,10H,6H2,1H3;(H,6,7)
InChI key:
OUFCGDLCPNGVPI-UHFFFAOYSA-N
form: solid
SMILES string: NC(C)C1=NC(CC)=NO1.O=C(C(F)(F)F)O
InChI: 1S/C6H11N3O.C2HF3O2/c1-3-5-8-6(4(2)7)10-9-5;3-2(4,5)1(6)7/h4H,3,7H2,1-2H3;(H,6,7)
InChI key: DMUDJJQKSFZITG-UHFFFAOYSA-N
form:
solid
SMILES string:
NC(C)C1=NC(CC)=NO1.O=C(C(F)(F)F)O
InChI:
1S/C6H11N3O.C2HF3O2/c1-3-5-8-6(4(2)7)10-9-5;3-2(4,5)1(6)7/h4H,3,7H2,1-2H3;(H,6,7)
InChI key:
DMUDJJQKSFZITG-UHFFFAOYSA-N
form: solid
SMILES string: OCC1=CC=CC=C1CN2CCOCC2.[H]Cl
InChI: 1S/C12H17NO2.ClH/c14-10-12-4-2-1-3-11(12)9-13-5-7-15-8-6-13;/h1-4,14H,5-10H2;1H
InChI key: TWHUKYCBXUAWLK-UHFFFAOYSA-N
form:
solid
SMILES string:
OCC1=CC=CC=C1CN2CCOCC2.[H]Cl
InChI:
1S/C12H17NO2.ClH/c14-10-12-4-2-1-3-11(12)9-13-5-7-15-8-6-13;/h1-4,14H,5-10H2;1H
InChI key:
TWHUKYCBXUAWLK-UHFFFAOYSA-N
form: solid
SMILES string: CC(N(C(C=C1)=CC=C1F)N=C2C)=C2CN.[H]Cl
InChI: 1S/C12H14FN3.ClH/c1-8-12(7-14)9(2)16(15-8)11-5-3-10(13)4-6-11;/h3-6H,7,14H2,1-2H3;1H
InChI key: TUMSAPBILBJOCF-UHFFFAOYSA-N
form:
solid
SMILES string:
CC(N(C(C=C1)=CC=C1F)N=C2C)=C2CN.[H]Cl
InChI:
1S/C12H14FN3.ClH/c1-8-12(7-14)9(2)16(15-8)11-5-3-10(13)4-6-11;/h3-6H,7,14H2,1-2H3;1H
InChI key:
TUMSAPBILBJOCF-UHFFFAOYSA-N